Oric Pharmaceuticals Inc
F:4TZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oric Pharmaceuticals Inc
F:4TZ
|
US |
|
P
|
Pharol SGPS SA
DUS:PTCA
|
PT |
|
B
|
Bayer AG
DUS:BAYN
|
DE |
|
R
|
Region Re Ltd
ASX:RGN
|
AU |
|
SSAB AB
F:SKWA
|
SE |
|
D
|
Danakali Ltd
F:SO3
|
AU |
|
Vale Indonesia Tbk PT
IDX:INCO
|
ID |
|
T
|
TRYP Therapeutics Inc
CNSX:TRYP
|
CA |
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
AU |
|
W
|
Wacker Neuson SE
XMUN:WAC
|
DE |
|
I
|
International Seaways Inc
XBER:IS5
|
US |
|
H
|
Hubtown Ltd
BSE:532799
|
IN |
|
Watkin Jones PLC
F:0W0
|
UK |
|
Moberg Pharma AB (publ)
OTC:MBGPF
|
SE |
|
WOLVES HAND Co Ltd
TSE:194A
|
JP |
|
Helical PLC
OTC:HLICF
|
UK |
|
Saga Pure ASA
OSE:SAGA
|
NO |
|
I
|
Incannex Healthcare Ltd
F:IQI
|
AU |
|
Fuerte Metals Corp
XTSX:TALA
|
CA |
|
Liberty Latin America Ltd
F:1LL
|
US |
|
Promotora de Informaciones SA
F:PZ41
|
ES |
|
Actinium Pharmaceuticals Inc
F:7AY1
|
US |
|
Office Properties Income Trust
NASDAQ:OPI
|
US |
Wall St Price Targets
4TZ Price Targets Summary
Oric Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
4TZ is 20.778 EUR with a low forecast of 14.342 EUR and a high forecast of 26.625 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4TZ's stock price target?
Price Target
20.778
EUR
According to Wall Street analysts, the average 1-year price target for
4TZ is 20.778 EUR with a low forecast of 14.342 EUR and a high forecast of 26.625 EUR.